BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26470797)

  • 1. Cyclosporine in psoriatic arthropathy.
    Soriano A; Pipitone N; Salvarani C
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S101-3. PubMed ID: 26470797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis.
    Mease PJ; Armstrong AW
    Drugs; 2014 Mar; 74(4):423-41. PubMed ID: 24566842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial design in psoriatic arthritis: what could be changed?
    Kavanaugh A; Boyd T
    Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S15-8. PubMed ID: 26458015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of low disease activity and remission in psoriatic arthritis.
    Lubrano E; Perrotta FM; Kavanaugh A
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S51-4. PubMed ID: 26470835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current concepts and new developments in the treatment of psoriatic arthritis.
    Pipitone N; Kingsley GH; Manzo A; Scott DL; Pitzalis C
    Rheumatology (Oxford); 2003 Oct; 42(10):1138-48. PubMed ID: 12810935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of cyclosporine A as monotherapy in patients with psoriatic arthritis: a subgroup analysis of the SYNERGY Study.
    Colombo D; Chimenti S; Grossi PA; Marchesoni A; Foti R; Calzavara-Pinton P; Zagni E; Ori A; Bellia G;
    G Ital Dermatol Venereol; 2017 Jun; 152(3):297-301. PubMed ID: 26837484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriatic arthritis. New types, new treatments.
    Ruzicka T
    Arch Dermatol; 1996 Feb; 132(2):215-9. PubMed ID: 8629831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary focus on cyclosporin A.
    Salvarani C; Boiardi L; Macchioni P; Pipitone N; Catanoso M; Pigatto P
    J Rheumatol Suppl; 2009 Aug; 83():52-5. PubMed ID: 19661542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriatic rheumatism. Inflammatory arthropathy.
    Macovei L; Brujbu I
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):45-51. PubMed ID: 24741774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of methotrexate in psoriatic arthritis: what is the evidence?
    Ianculescu I; Weisman MH
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S94-7. PubMed ID: 26470718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-12 and interleukin-23 inhibition in psoriatic arthritis.
    Johnsson HJ; McInnes IB
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S115-8. PubMed ID: 26471946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial.
    Karanikolas GN; Koukli EM; Katsalira A; Arida A; Petrou D; Komninou E; Fragiadaki K; Zacharioudaki A; Lasithiotakis I; Giavri E; Vaiopoulos G; Sfikakis PP
    J Rheumatol; 2011 Nov; 38(11):2466-74. PubMed ID: 21885499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Agents other than Tumor Necrosis Factor Blockers in the Treatment of Psoriatic Arthritis.
    Atzeni F; Costa L; Caso F; Scarpa R; Sarzi-Puttini P
    J Rheumatol Suppl; 2015 Nov; 93():79-81. PubMed ID: 26523064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs.
    Lubrano E; Scarpa R
    Reumatismo; 2012 Jun; 64(2):107-12. PubMed ID: 22690387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can traditional disease-modifying anti-rheumatic drugs be withdrawn or tapered in psoriatic arthritis?
    Lubrano E; Soriano E; FitzGerald O
    Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S54-8. PubMed ID: 24129139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Tumor Necrosis Factor-α Blockers in Psoriatic Disease. Therapeutic Options in Psoriatic Arthritis.
    Addimanda O; Possemato N; Caruso A; Pipitone N; Salvarani C
    J Rheumatol Suppl; 2015 Nov; 93():73-8. PubMed ID: 26523063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriatic Disease: Update on Traditional Disease-modifying Antirheumatic Drugs.
    Marchesoni A; Lubrano E; Cauli A; Ricci M; Manara M
    J Rheumatol Suppl; 2015 Nov; 93():61-4. PubMed ID: 26523060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apremilast: A Review in Psoriasis and Psoriatic Arthritis.
    Deeks ED
    Drugs; 2015 Aug; 75(12):1393-403. PubMed ID: 26220911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing and treating psoriatic arthritis: an update.
    Boehncke WH; Qureshi A; Merola JF; Thaçi D; Krueger GG; Walsh J; Kim N; Gottlieb AB
    Br J Dermatol; 2014 Apr; 170(4):772-86. PubMed ID: 24266754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement.
    Simone D; Nowik M; Gremese E; Ferraccioli GF
    J Rheumatol Suppl; 2015 Nov; 93():65-9. PubMed ID: 26523061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.